Therapeutic effects of continuous infusion of brain natriuretic peptides on postmyocardial infarction ventricular remodelling in rats

Archives of Cardiovascular Diseases

Volumn 104, Issue 1, 2011, Pages 17-28

  Pan, Yesheng ^a   Zhu, Wei ^a   Ma, Jian ^a   Xin, Ping ^a   Han, Beibei ^a   He, Yaping ^a   Wang, Yanpeng ^a   Peng, Tianqing ^b   Wei, Meng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Brain natriuretic peptide; Matrix metalloproteinase; Myocardial infarction; NF B; Remodelling

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; CYTOKINE; ENALAPRIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; PROTEIN P50; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; EXTRACELLULAR MATRIX; GEOMETRY; HEART; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE REMODELING; MALE; NONHUMAN; OSMOTIC PUMP; POSTMYOCARDIAL INFARCTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SHAM PROCEDURE; SURVIVAL RATE; THERAPY EFFECT;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARDIOVASCULAR AGENTS; COLLAGEN; CYCLIC GMP; DISEASE MODELS, ANIMAL; ENALAPRIL; HEMODYNAMICS; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRAVENOUS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCARDIAL INFARCTION; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; NF-KAPPA B P50 SUBUNIT; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION FACTOR RELA; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 79251612323     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2010.09.006     Document Type: Article

References (32)

1. T. Nishi Kim, N. Maeda, and H. Matsuoka The role of natriuretic peptides in cardioprotection Cardivasc Res 69 2006 318 328
2. G.F. Baxter The natriuretic peptides Basic Res Cardiol 99 2004 71 75
3. N. Hama, H. Itoh, and G. Shirakami Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction Circulation 92 1995 1558 1564
4. S.P. D'Souza, D.M. Yellon, and C. Martin B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening Am J Physiol Heart Circ Physiol 284 2003 H1592 H1600
5. P.M. Oliver, J.E. Fox, and R. Kim Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A Proc Natl Acad Sci U S A 94 1997 14730 14735
6. T. Tokudome, T. Horio, and I. Kishimoto Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides Circulation 111 2005 3095 3104
7. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287(12):1531-40.
8. W.S. Colucci, U. Elkayam, and D.P. Horton Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure N Engl J Med 343 2000 246 253
9. R.J. Hillock, C.M. Frampton, and T.G. Yandle B-type natriuretic peptide infusions in acute myocardial infarction Heart 94 2008 617 622
10. J. He, Y. Chen, and Y. Huang Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats Eur J Pharmacol 602 2009 132 137
11. A.S. Baldwin Jr. Series introduction: the transcription factor NF-kappaB and human disease J Clin Invest 107 2001 3 6
12. E. Vellaichamy, N.K. Sommana, and K.N. Pandey Reduced cGMP signaling activates NF-kappaB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A Biochem Biophys Res Commun 327 2005 106 111
13. X. Zhang, M. Wei, and W. Zhu Combined transplantation of endothelial progenitor cells and mesenchymal stem cells into a rat model of isoproterenol-induced myocardial injury Arch Cardiovasc Dis 101 2008 333 342
14. H. Ju, S. Zhao, and D.S. Jassal Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction Cardiovasc Res 35 1997 223 232
15. P. Xin, W. Zhu, and J. Li Combined local ischemic postconditioning and remote perconditioning recapitulate cardioprotective effects of local ischemic preconditioning Am J Physiol Heart Circ Physiol 298 2010 H1819 H1831
16. M. Nian, P. Lee, and N. Khaper Inflammatory cytokines and postmyocardial infarction remodeling Circ Res 94 2004 1543 1553
17. C. Freund, R. Schmidt-Ullrich, and A. Baurand Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo Circulation 111 2005 2319 2325
18. N. Kawamura, T. Kubota, and S. Kawano Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy Cardiovasc Res 66 2005 520 529
19. S. Frantz, K. Hu, and B. Bayer Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction FASEB J 20 2006 1918 1920
20. S. Frantz, J. Tillmanns, and P.J. Kuhlencordt Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury Am J Pathol 171 2007 507 512
21. Y. Onai, J. Suzuki, and Y. Maejima Inhibition of NF-kappaB improves left ventricular remodeling and cardiac dysfunction after myocardial infarction Am J Physiol Heart Circ Physiol 292 2007 H530 H538
22. L. Timmers, J.K. van Keulen, and I.E. Hoefer Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction Circ Res 104 2009 699 706
23. J. Shaw, N. Yurkova, and T. Zhang Antagonism of E2F-1 regulated Bnip3 transcription by NF-kappaB is essential for basal cell survival Proc Natl Acad Sci U S A 105 2008 20734 20739
24. Y. Sakata, K. Yamamoto, and T. Mano Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of angiotensin-converting enzyme inhibitor Circulation 109 2004 2139 2143
25. A. Hoffmann, A. Levchenko, and M.L. Scott The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation Science 298 2002 1241 1245
26. R. Kawakami, Y. Saito, and I. Kishimoto Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction Circulation 110 2004 3306 3312
27. T. Tsuruda, G. Boerriger, and B.K. Huntley Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases Circ Res 91 12 2002 1127 1134
28. S. Matsumura, S. Iwanaga, and S. Mochizuki Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice J Clin Invest 115 2005 599 609
29. M. Bujak, and N.G. Frangogiannis The role of TGF-beta signaling in myocardial infarction and cardiac remodeling Cardiovasc Res 74 2007 184 195
30. D. Seo, and J.M. Hare The transforming growth factor-beta/Smad3 pathway: coming of age as a key participant in cardiac remodeling Circulation 116 2007 2096 2098
31. A.M. Kapoun, F. Liang, and G. O'Young B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation Circ Res 94 2004 453 461
32. B.I. Jugdutt Effect of nitrates on myocardial remodeling after acute myocardial infarction Am J Cardiol 77 1996 17C 23C